Article
Insights into the role of the JAK/STAT signaling pathway in graft- versus -host disease
1 Jan 2020
Abstract excerpt
Allogeneic hematopoietic transplantation (allo-HCT) is a curative therapy for a variety of hematologic malignancies, primarily through immune-mediated clearance of malignant cells. This graft- versus-leukemia (GvL) effect is mediated by alloreactive donor T-cells against recipient malignant cells. Unfortunately, graft versus host disease is a potentially lethal complication of this procedure, also mediated by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
